Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-064255

Intra-Cellular Therapies, Inc. · ITCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert E Davis
Officer — SVP, Chief Scientific Officer
Period of report
Dec 4, 2017
Accepted (ET)
Dec 6, 2017 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 4, 2017M1,757—A28,514D
Common StockF3Dec 5, 2017S650$15.00D27,864D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Dec 4, 2017M1,757D——Common Stock1,7571,758D

Explanation of responses